Mechanical Ventilators (Ventilator)

Subscribe to Selected New Research on Mechanical Ventilators

3759 relevant articles (153 outcomes, 258 trials/studies) found for this Therapy

Description: Mechanical devices used to produce or assist pulmonary ventilation.

Also Known As:

Ventilator; Respirator; Respirators; Ventilators; Ventilators, Mechanical; Pulmonary Ventilator; Pulmonary Ventilators; Ventilator, Pulmonary; Mechanical Ventilator; Ventilator, Mechanical; Ventilators, Pulmonary

Relationship Network

Therapy Context: Research Results

Equipment and Supplies

Mechanical Ventilators: 3759

Negative-Pressure Ventilators: 14

Experts

1.	Gajic, Ognjen: 4 articles (05/2008 - 09/2004)
2.	Hubmayr, Rolf D: 4 articles (05/2008 - 09/2004)
3.	Quinn, Deborah A: 3 articles (05/2008 - 08/2002)
4.	Slutsky, Arthur S: 3 articles (07/2006 - 12/2002)
5.	Branson, Richard D: 2 articles (09/2008 - 06/2005)
6.	Hales, Charles A: 2 articles (05/2008 - 08/2002)
7.	Honarmand, Azim: 2 articles (04/2008 - 07/2007)
8.	Safavi, Mohammadreza: 2 articles (04/2008 - 07/2007)
9.	Garcia, Joe G N: 2 articles (01/2008 - 01/2005)
10.	Branson, Richard: 2 articles (07/2007 - 04/2007)

Related Diseases

1.	Respiratory Insufficiency (Respiratory Failure) 04/01/2003 - "CONCLUSION: The prone position may prove beneficial in some cases of hypoxemic respiratory failure, even in awake patients, by avoiding mechanical ventilation and ventilator-associated complications." 08/01/1996 - "CONCLUSIONS: Administration of calf's lung surfactant appears to be safe and is associated with rapid improvement in oxygenation and moderation of ventilator support in children with acute hypoxemic respiratory failure. " 06/01/1981 - "Results indicate that regular efficient night-time support by body respirator provides a constant significant improvement in daytime gas exchange for periods averaging up to 2 years following the occurrence of moderately severe respiratory failure. " 07/01/1989 - "Home care of ventilator-dependent people is increasing in use due to improved management of respiratory failure and the development of effective portable ventilators. " 02/01/1991 - "The results of this initial trial suggest that the volumetric diffusive respirator is a safe and effective method of ventilation in neonates with respiratory failure and that the survival rate in such neonates might be enhanced if treatment is introduced earlier in the disease." Order ALL the reference details at left...
2.	Pneumonia (Pneumonitis) 02/01/2006 - "This is being caused by a decline in ventilator associated pneumonias, most likely because non-invasive ventilation allows patients to clear their secretions by coughing, resulting in improved lung clearance. " 04/01/2006 - "Length of stay in the intensive care unit and need for ventilator support were significantly greater for patients with pneumonia (p < .01). " 06/01/2000 - "The rapid institution of appropriate antimicrobial therapy has been shown to improve mortality in patients with ventilator associated nosocomial pneumonia. " 02/01/2002 - "Several new drugs for the treatment of ventilator-assisted pneumonia caused by Gram-positive multiresistant pathogens have been evaluated with promising results." 12/01/2007 - "Additional benefits may include a decreased rate of ventilator associated with pneumonia and improved growth." Order ALL the reference details at left...
3.	Lung Diseases (Lung Disease) 09/01/2004 - "OBJECTIVE: Although earlier studies have suggested that early continuous airway positive pressure (CPAP) may be beneficial in reducing ventilator dependence and subsequent chronic lung disease in the extremely low birth weight (ELBW) infant, the time of initiation of CPAP has varied, and there are no prospective studies of infants who have received CPAP or positive end-expiratory pressure (PEEP) from initial resuscitation in the delivery room (DR). " 01/01/1997 - "Although high-frequency ventilators (HFV) may be less effective in patients with lung diseases complicated by high airway resistance, such as BPD, high-frequency oscillatory ventilators (HFOV) can still provide an alternative treatment of choice due to its property of active exhalation, in addition to its tidal volume being less than dead space and its minute ventilation being more dependent on tidal volume. " 05/01/2006 - "CONCLUSION: Lung transplantation is effective for the treatment of ventilator dependent end-stage lung diseases." 09/01/2004 - "METHODS: We conducted a bench study with a neonatal ventilator-lung model that included a Bird VIP ventilator, in a time-cycled, pressure-limited, continuous-flow mode, with settings to simulate a 1-kg infant with moderate lung disease: peak inspiratory pressure 25 cm H2O, positive end-expiratory pressure 4 cm H2O, respiratory rate 30 breaths/min, inspiratory time 0.35 s, tidal volume approximately 7 mL. The circuit was attached to a 3.0-mm inner-diameter endotracheal tube and a neonatal test lung. " 01/01/2002 - "METHODS: In this study, 20 patients with severe lung disease requiring ventilator support, were recruited. " Order ALL the reference details at left...
4.	Lung Injury 02/01/2003 - "CONCLUSIONS: The excellent alveolar recruitment suggests that liquid ventilation ameliorates ventilator-associated lung injury." 04/01/2005 - "Protective effects of low respiratory frequency in experimental ventilator-associated lung injury." 11/01/2000 - "As a result of an improved understanding that mechanical ventilation itself can contribute to and aggravate the disease process, the term ventilator-associated lung injury (VALI) has been introduced. " 05/01/2008 - "Volutrauma and atelectrauma have been proposed as mechanisms of ventilator-associated lung injury, but few studies have compared their relative importance in mediating lung injury. " 06/01/2007 - "Studies of ventilator-associated lung injury in subjects without ALI demonstrate inconsistent results. " Order ALL the reference details at left...
5.	Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/01/2003 - "Length of hospital stay, number of ventilator days, and percentage of patients developing acute respiratory distress syndrome were significantly greater in the > 24-hour group. " 09/01/1994 - "However, changes in ventilator strategies and improved critical care management may result in better survival rates in patients with well-defined, severe adult respiratory distress syndrome. " 03/01/2008 - "CONCLUSIONS: OTZ does not improve survival or reduce ventilator time in patients with acute respiratory distress syndrome and may worsen outcome, although mortality in the OTZ group was similar or lower than most similar trials. " 01/01/2008 - "BACKGROUND: The purpose of this study was to evaluate the feasibility of integrating an artificial, pumpless extracorporeal membrane ventilator (Novalung) to near static mechanical ventilation and its efficacy in patients with severe postresectional acute respiratory distress syndrome (ARDS) unresponsive to optimal conventional treatment. " 03/01/2007 - "Recently, the Acute Respiratory Distress Syndrome Network Fluid and Catheter Treatment Trial reported that a conservative fluid management strategy, compared with a fluid liberal strategy, increased the mean (+/- SE) number of ventilator-free days in patients with ALI (14.6 +/- 0.5 vs 12.1 +/- 0.5 days, respectively; p < 0.001). " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Oxygen
2.	Steroids
3.	Adrenal Cortex Hormones (Corticosteroids)
4.	Tolazoline (Priscoline)
5.	Methylprednisolone
6.	Dexamethasone (Maxidex)
7.	Carbon Dioxide
8.	ONO 5046 (sivelestat)
9.	Anti-Bacterial Agents (Antibiotics)
10.	Nitric Oxide (Nitrogen Monoxide)

Related Therapies and Procedures

1.	Positive-Pressure Respiration (PEEP)
2.	Mechanical Ventilators (Ventilator)
3.	Artificial Respiration (Mechanical Ventilation)
4.	Length of Stay
5.	Intensive Care (Surgical Intensive Care)

Best Treatments:
Research Summary Report
on Respiratory Insufficiency

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 505 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>